Predicting GLP-1 Discontinuation From Pharmacy Claims
Published: | Updated:
|Articles|July 1, 1999
The American Journal of Managed Care
- July 1999
- Volume 5
- Issue 7
The Cost of Alzheimer's Disease in Managed Care: A Cross-Sectional Study
Author(s)Joel Leon, PhD, Peter Neumann, ScD
Advertisement
Articles in this issue
about 27 years ago
Hospital Expenditures and Utilization: The Impact of HMOsabout 27 years ago
Payor Cost Savings with Endometrial Ablation Therapyabout 27 years ago
The Food and Drug Administration and Atrial Defibrillation Devicesabout 27 years ago
Benign Prostatic Hyperplasia: New Concepts for the Millenniumabout 27 years ago
Breast Cancer Prevention: The Role of Antiestrogensabout 27 years ago
The Impact of HMOs on Hospital Use and Cost? A Matter of InterpretationAdvertisement
Related Content
Advertisement
Advertisement
Trending on AJMC
1
CMS Final Rule Ends Federal Medicaid, CHIP Funding for Youth Gender-Affirming Care
2
Trump Childhood Vaccine Order: What It Means for Parents and Payers
3
CAR T, Bispecifics Reshape Relapsed Lymphoma Care: Madhav Seshadri, MD
4
OCTOPUS Trial Aims to Speed Access to Rare Sarcoma Drugs
5